191 related articles for article (PubMed ID: 22048626)
21. Clinical relevance of
Cayrefourcq L; Alix-Panabières C
Expert Rev Mol Diagn; 2020 Sep; 20(9):913-919. PubMed ID: 32856493
[TBL] [Abstract][Full Text] [Related]
22. [Circulating tumor cells: cornerstone of personalized medicine].
Rafii A; Vidal F; Rathat G; Alix-Panabières C
J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):640-8. PubMed ID: 25017712
[TBL] [Abstract][Full Text] [Related]
23. Is there a role for circulating tumor cells in the management of breast cancer?
Hayes DF; Smerage J
Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.
Sawada T; Araki J; Yamashita T; Masubuchi M; Chiyoda T; Yunokawa M; Hoshi K; Tao S; Yamamura S; Yatsushiro S; Abe K; Kataoka M; Shimoyama T; Maeda Y; Kuroi K; Tamura K; Sawazumi T; Minami H; Suda Y; Koizumi F
EBioMedicine; 2016 Sep; 11():173-182. PubMed ID: 27495793
[TBL] [Abstract][Full Text] [Related]
25. Markers of circulating breast cancer cells.
López-Muñoz E; Méndez-Montes M
Adv Clin Chem; 2013; 61():175-224. PubMed ID: 24015603
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients.
Reyal F; Valet F; de Cremoux P; Mathiot C; Decraene C; Asselain B; Brain E; Delaloge S; Giacchetti S; Marty M; Pierga JY; Bidard FC
Ann Oncol; 2011 Jun; 22(6):1458-1459. PubMed ID: 21525400
[No Abstract] [Full Text] [Related]
27. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.
Vismara M; Reduzzi C; Daidone MG; Cappelletti V
Adv Exp Med Biol; 2020; 1220():81-91. PubMed ID: 32304081
[TBL] [Abstract][Full Text] [Related]
29. Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer.
Harigopal M; Kowalski D; Vosoughi A
Expert Rev Mol Diagn; 2020 Aug; 20(8):815-828. PubMed ID: 32546017
[TBL] [Abstract][Full Text] [Related]
30. Gelatin Nanoparticle-Coated Silicon Beads for Density-Selective Capture and Release of Heterogeneous Circulating Tumor Cells with High Purity.
Huang Q; Wang FB; Yuan CH; He Z; Rao L; Cai B; Chen B; Jiang S; Li Z; Chen J; Liu W; Guo F; Ao Z; Chen S; Zhao XZ
Theranostics; 2018; 8(6):1624-1635. PubMed ID: 29556345
[No Abstract] [Full Text] [Related]
31. By the numbers: does circulating tumor cell enumeration have a role in metastatic breast cancer?
Liu MC
J Clin Oncol; 2014 Nov; 32(31):3479-82. PubMed ID: 25245442
[No Abstract] [Full Text] [Related]
32. Precision medicine in breast cancer.
Naito Y; Urasaki T
Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
[TBL] [Abstract][Full Text] [Related]
33. Circulating cancer cells in division in an early breast cancer patient.
Serrano MJ; Nadal R; Lorente JA; Salido M; Rodríguez R; Rodríguez M; Macià M; Sánchez-Rovira P; Corominas JM; González L; Vera L; Albanell J; Solé F
Ann Oncol; 2011 Sep; 22(9):2150-2151. PubMed ID: 21743104
[No Abstract] [Full Text] [Related]
34. Circulating tumor cells in the clinical cancer diagnosis.
Zhang P; Zhou H; Lu K; Wang Y; Feng T
Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and predictive biomarkers in breast cancer: Past, present and future.
Nicolini A; Ferrari P; Duffy MJ
Semin Cancer Biol; 2018 Oct; 52(Pt 1):56-73. PubMed ID: 28882552
[TBL] [Abstract][Full Text] [Related]
36. Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer.
Bredemeier M; Edimiris P; Mach P; Kubista M; Sjöback R; Rohlova E; Kolostova K; Hauch S; Aktas B; Tewes M; Kimmig R; Kasimir-Bauer S
Clin Chem; 2017 Oct; 63(10):1585-1593. PubMed ID: 28778937
[TBL] [Abstract][Full Text] [Related]
37. Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?
Dawood S; Cristofanilli M
Pharmacogenomics; 2015; 16(7):669-72. PubMed ID: 25950463
[No Abstract] [Full Text] [Related]
38. Clinical relevance and biology of circulating tumor cells.
Bednarz-Knoll N; Alix-Panabières C; Pantel K
Breast Cancer Res; 2011; 13(6):228. PubMed ID: 22114869
[TBL] [Abstract][Full Text] [Related]
39. Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.
Deutsch TM; Riethdorf S; Nees J; Hartkopf AD; Schönfisch B; Domschke C; Sprick MR; Schütz F; Brucker SY; Stefanovic S; Sohn C; Pantel K; Trumpp A; Schneeweiss A; Wallwiener M
Breast Cancer Res Treat; 2016 Nov; 160(2):277-290. PubMed ID: 27696083
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cells: personalized medicine in interventional oncology?
Sheth RA; Hesketh R; Deipolyi AR; Oklu R
J Vasc Interv Radiol; 2013 Feb; 24(2):221-8. PubMed ID: 23265726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
